Infographic Summary of the Study (IMAGE)
Caption
Representation of the B-cell receptor's signaling pathway (right). Masitinib treatment inhibits tumor growth in DLBCL patients-derived tumors (left).
Credit
E. Oricchio/EPFL
Usage Restrictions
Media purposes.
License
Licensed content